[Ip-health] [paper] Drug Pricing Trends for Orally Administered Anticancer Medications

Irene Romero irene.romero.07 at gmail.com
Thu Sep 1 11:37:35 PDT 2016


You have probably seen this already...
Recent paper published JAMA Oncology (
http://oncology.jamanetwork.com/article.aspx?articleid=2517398) on a study
of Anticancer Drugs Prices from 2000 to 2014.
The design of the study is interesting too --  how they adapted
expenditures taking into account inflation, etc.
Also useful to get an estimate of monthly expenditure for each compound.

Interestingly, thalidomide (which is one of the oldest compounds analyzed,
even though it has not been used originally for cancer) is one of the
treatments with the greatest increase in expenditure throughout the years.

I have added below the full-text pdf (pay walls are bad for health).


Irene Romero Bhathal
*Universities Allied for Essential Medicines (UAEM) -- Spain*
*www.uaem.org <http://www.uaem.org>*
skype: ireneromero294
@iromerob_ <http://www.twitter.com/iromerob_>

More information about the Ip-health mailing list